Ellerson Group Inc. ADV trimmed its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 3.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,710 shares of the medical equipment provider’s stock after selling 60 shares during the quarter. Intuitive Surgical accounts for about 0.7% of Ellerson Group Inc. ADV’s investment portfolio, making the stock its 28th biggest position. Ellerson Group Inc. ADV’s holdings in Intuitive Surgical were worth $893,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also modified their holdings of the business. State Street Corp increased its position in shares of Intuitive Surgical by 1.4% during the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock worth $7,393,673,000 after acquiring an additional 210,363 shares during the last quarter. FMR LLC increased its position in shares of Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after acquiring an additional 838,793 shares during the last quarter. Geode Capital Management LLC increased its position in shares of Intuitive Surgical by 1.9% during the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock worth $3,677,194,000 after acquiring an additional 143,440 shares during the last quarter. Fisher Asset Management LLC increased its position in shares of Intuitive Surgical by 1.8% during the fourth quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock worth $2,541,356,000 after acquiring an additional 86,488 shares during the last quarter. Finally, Baillie Gifford & Co. increased its position in shares of Intuitive Surgical by 0.6% during the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock worth $1,890,676,000 after acquiring an additional 24,183 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of analysts have recently issued reports on the company. Truist Financial lifted their target price on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. JPMorgan Chase & Co. boosted their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. BTIG Research boosted their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Citigroup boosted their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday, January 24th. Finally, Barclays boosted their price objective on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.
Insiders Place Their Bets
In other Intuitive Surgical news, SVP Mark Brosius sold 489 shares of the company’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $533.18, for a total value of $260,725.02. Following the completion of the sale, the senior vice president now directly owns 2,091 shares in the company, valued at $1,114,879.38. This represents a 18.95 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Fredrik Widman sold 810 shares of the company’s stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total value of $464,761.80. Following the completion of the sale, the vice president now owns 473 shares of the company’s stock, valued at $271,397.94. This trade represents a 63.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 13,579 shares of company stock worth $7,756,844 over the last ninety days. Company insiders own 0.90% of the company’s stock.
Intuitive Surgical Price Performance
ISRG opened at $518.26 on Friday. The company has a market capitalization of $184.59 billion, a price-to-earnings ratio of 80.85, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The business has a 50 day moving average price of $571.36 and a two-hundred day moving average price of $531.53.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- Insider Trades May Not Tell You What You Think
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- What Investors Need to Know to Beat the Market
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- Consumer Staples Stocks, Explained
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.